"Studies show that repeated
use of CHG soap enhances the ability of CHG to reduce bacterial counts
on the skin not only during the immediate period after the shower but for a
number of hours afterward." http://www.ihi.org/ProjectJOINTS
“A
standardized preadmission shower regimen that includes 118 mL (full 4 oz
bottle) of aqueous chlorhexidine gluconate, 4%, per shower; a minimum of 2
sequential showers;
and a 1-minute pause before rinsing results in maximal skin surface (16.5 µg/cm)
concentrations of chlorhexidine gluconate that are sufficient to inhibit or
kill gram-positive or gram-negative surgical wound pathogens. This showering
regimen corrects deficiencies present in current non standardized preadmission
shower protocols for patients undergoing elective surgery.” Edmiston, et al. JAMA Aug 2015
Pre-op Showers with Chlorhexidine Washcloths
http://www.sageproducts.com/
The First FDA-Approved Preoperative Skin Prep in a Cloth
Sage 2% CHG Cloths address multidrug resistant organisms (MDROs) on the
patients' skin - a known risk factor for SSIs.1 Sage's innovative rinse-free, alcohol-free formula is designed for early preop prep. It stays on the skin for maximum persistence. The cloth consistently delivers a uniform dose of CHG, unlike other soaps and solutions.
2% FORMULA PROVEN EFFECTIVE
Effective against broad spectrum of MDROs, including MRSA, VRE
and Acinetobacter. Recognized by CDC as having "excellent" activity against gram-positive bacteria as well as "excellent" residual activity
Sage 2% CHG Cloths address multidrug resistant organisms (MDROs) on the
patients' skin - a known risk factor for SSIs.1 Sage's innovative rinse-free, alcohol-free formula is designed for early preop prep. It stays on the skin for maximum persistence. The cloth consistently delivers a uniform dose of CHG, unlike other soaps and solutions.
2% FORMULA PROVEN EFFECTIVE
Effective against broad spectrum of MDROs, including MRSA, VRE
and Acinetobacter. Recognized by CDC as having "excellent" activity against gram-positive bacteria as well as "excellent" residual activity
Hibiclens Chlorhexidine Antiseptic Skin Cleanser
http://www.hibigeebies.com/
Hibiclens® the antimicrobial antiseptic skin cleanser can be an effective defense for preventing the spread of MRSA and other staph infections in your facilities. Its active ingredient, CHG works in a unique way- it kills germs on contact and bonds with the skin to keep killing microorganisms even after washing.
HIBICLENS is bactericidal on contact. It has antiseptic activity and a
persistent antimicrobial effect with rapid bactericidal activity against a wide
range of microorganisms, including gram-positive bacteria and gram-negative
bacteria such as Pseudomonas aeruginosa. The effectiveness of HIBICLENS is not
significantly reduced by the presence of organic matter, such as blood. In a study simulating surgical use, the immediate bactericidal effect of HIBICLENS after a single six-minute scrub resulted in a 99.9% reduction in resident bacterial flora, with a reduction of 99.98% after the eleventh scrub. Reductions on surgically gloved hands were maintained over the six-hour test period. HIBICLENS displays persistent antimicrobial action. In one study, 93% of a radiolabeled formulation of HIBICLENS remained present on uncovered skin after five hours. HIBICLENS helps prevent skin infection thereby
reducing the risk of cross-infection.
HIBICLENS is bactericidal on contact. It has antiseptic activity and a
persistent antimicrobial effect with rapid bactericidal activity against a wide
range of microorganisms, including gram-positive bacteria and gram-negative
bacteria such as Pseudomonas aeruginosa. The effectiveness of HIBICLENS is not
significantly reduced by the presence of organic matter, such as blood. In a study simulating surgical use, the immediate bactericidal effect of HIBICLENS after a single six-minute scrub resulted in a 99.9% reduction in resident bacterial flora, with a reduction of 99.98% after the eleventh scrub. Reductions on surgically gloved hands were maintained over the six-hour test period. HIBICLENS displays persistent antimicrobial action. In one study, 93% of a radiolabeled formulation of HIBICLENS remained present on uncovered skin after five hours. HIBICLENS helps prevent skin infection thereby
reducing the risk of cross-infection.
The StartClean Cleansing Program
http://www.carefusion.com/medical-products/infection-prevention/general-skin-cleanser/
Cleansers only work if your patients use them.
That’s why the StartClean cleansing program uses an individual patient reminder system to help you and your patients improve preoperative bathing compliance.
.Order The Kit
Each kit includes one bottle of 4% CHG, three single-use sponges and a patient education template.
Schedule The Reminder
Patients receive a text, email or voice mail reminding them to use their antiseptic cleanser prior to surgery.
Customize Patient Education
The additional reminder should help patients adhere to your bathing instructions prior to surgery.*
http://www.carefusion.com/medical-products/infection-prevention/general-skin-cleanser/
Cleansers only work if your patients use them.
That’s why the StartClean cleansing program uses an individual patient reminder system to help you and your patients improve preoperative bathing compliance.
.Order The Kit
Each kit includes one bottle of 4% CHG, three single-use sponges and a patient education template.
Schedule The Reminder
Patients receive a text, email or voice mail reminding them to use their antiseptic cleanser prior to surgery.
Customize Patient Education
The additional reminder should help patients adhere to your bathing instructions prior to surgery.*
| ip_startclean-patient-ed-template_pe.pdf |
| Edmiston et al. Chlorehexidine_Pre-Op_Methodology_JAMA Surgery_2015.pdf |
| Infection Control_Today_CHG_Bathing_report.pdf |
| Edmiston_et_al_JACS_2014_Empowerng_the_Surgical_Patient_for_Preop_Shower.pdf |
| Lipke_and_Hyott_-_Reducing_SSIs_by_Bundling_Multiple_rRsk_Reduction_Strategies_and_Active_Surveillance_-_AORN_2010.pdf |
| APIC_Symposium_-_CHG_Irrigation_Bathing_and_Skin_Antisepsis_June_6_2012_3.pdf |
| Edmiston, et l JACS_2008_CHG_Washcloths.pdf |
| IHI_Project_Joints_-_CHG_Bathing.ppt |
| Clinical_References_for_CHG_Washcloths.doc |
| Johnson-Mont_JOA_April_2010_CHG_Washcloths.pdf |
| Poster_on_C_Section_Reduction_with_CHG_Cloths.pdf |
| Lipke_C Section.pdf |
| CHG_C Section.pdf |
| Hendrickson_C Section.pdf |
| Start Clean Education Template_en.pdf |
